Formulation study of topically applied O/W lotion containing vitamin D3 derivative, focusing on skin permeability of the drug

References

• Polano MK, Bonsel J, van der Meer BJ. (1950). The relation between the effect of topical irritants and the ointment bases in which they are applied to the skin. Dermatologica, 101:69–79.
   PubMedGoogle Scholar
• Hadgraft J. (1989). Formulation of anti-inflammatory agents. In: Hensby C, Lowe NJ (eds.), Nonsteroidal anti-inflammatory drugs. Pharmacol. Skin. Basel, Karger, 2, 21–43.
   Google Scholar
• Pershing LK, Silver BS, Krueger GG, Shah VP, Skelley JP. (1992). Feasibility of measuring the bioavailability of topical betamethasone dipropionate in commercial formulations using drug content in skin and a skin blanching bioassay. Pharm Res, 9:45–51.
   PubMed Web of Science ®Google Scholar
• Christian STT, Smith EW. (2002). Ointment, cream, and lotion as topical drug delivery system. In: Robert L, Bronaugh HI (eds.), Topical absorption of dermatological products. Fragrance Journal, Tokyo.
   Google Scholar
• Smith EW, Meyer E, Haigh JM. (1990). Blanching activities of betamethasone formulations. The effect of dosage form on topical drug availability. Arzneimittelforschung, 40:618–621.
   PubMed Web of Science ®Google Scholar
• Haigh JM, Smith EW, Meyer E, Fassihi R. (1992). Influence of the oil phase dispersion in a cream base on the in vivo release of betamethasone 17-valerate. S.T.P. Pharma Sciences, 2:259–264.
   Google Scholar
• Richard B, Stoughton MD. (1987). Are generic formulations equivalent to trade name topical glucocorticoids? Arch Dermatol, 123:1312–1314.
   PubMed Web of Science ®Google Scholar
• Stoughton RB, Wullich K. (1989). The same glucocorticoid in brand-name products. Does increasing the concentration result in greater topical biologic activity? Arch Dermatol, 125:1509–1511.
   PubMed Web of Science ®Google Scholar
• Somerma S. (1980). The chamber vasoconstrictor assay. I. Comparison with occluded and unoccluded tests using four corticosteroids. Clin Exp Dermatol, 5:191–196.
   PubMed Web of Science ®Google Scholar
• Smith EW, Meyer E, Haigh JM, Maibach HI. (1991). The human skin blanching assay for comparing topical corticosteroid availability. J Dermatol Treat, 2:69–72.
   Google Scholar
• Gao HY, Li Wan Po A. (1994). Topical formulations of fluocinolone acetonide. Are creams, gels and ointments bioequivalent and does dilution affect activity? Eur J Clin Pharmacol, 46:71–75.
   PubMed Web of Science ®Google Scholar
• Trottet L, Owen H, Holme P, Heylings J, Collin IP, Breen AP et al. (2005). Are all aciclovir cream formulations bioequivalent? Int J Pharm, 304:63–71.
   PubMed Web of Science ®Google Scholar
• Tsai J, Chuang S, Hsu M, Sheu H. (1999). Distribution of salicylic acid in human stratum corneum following topical application in vivo: a comparison of six different formulations. Int J Pharm, 188:145–153.
   PubMed Web of Science ®Google Scholar
• Ostrenga J, Steinmetz C, Poulsen B. (1971a). Significance of vehicle composition. I. Relationship between topical vehicle composition, skin penetrability, and clinical efficacy. J Pharm Sci, 60:1175–1179.
   PubMed Web of Science ®Google Scholar
• Ostrenga J, Steinmetz C, Poulsen B, Yett S. (1971b). Significance of vehicle composition. II. Prediction of optimal vehicle composition. J Pharm Sci, 60:1180–1183.
   PubMed Web of Science ®Google Scholar
• Ostrenga J, Steinmetz C, Poulsen B, Yett S. (1971c). Significance of vehicle composition. II. Prediction of optimal vehicle composition. J Pharm Sci, 60:1180–1183.
   PubMed Web of Science ®Google Scholar
• Hadgraft J. (1999). Passive enhancement strategies in topical and transdermal drug delivery. Int J Pharm, 184:1–6.
   PubMed Web of Science ®Google Scholar
• Kumar S, Malick AW, Meltzer NM, Mouskountakis JD, Behl CR. (1992). Studies of in vitro skin permeation and retention of a leukotriene antagonist from topical vehicles with a hairless guinea pig model. J Pharm Sci, 81:631–634.
   PubMed Web of Science ®Google Scholar
• Adnan A., Zeenat IK, Aqil M, Farhan JA, Roop KK, Sushama T. (2009). Microemulsions as a surrogate carrier for dermal drug delivery. Drug Dev Ind Pharm, 35:525–547.
   PubMed Web of Science ®Google Scholar
• Rachna P, Sneh A, Roop KK, Amit KD, Veena K. (2009). Studies on in vitro and in vivo transdermal flux enhancement of methotrexate by a combinational approach in comparison to oral delivery. Drug Dev Ind Pharm, 35:1281–1292.
   PubMed Web of Science ®Google Scholar
• Karimunnisa SS, Bothiraja C, Atmaram PP. (2010). Studies on nonionic surfactant bilayer vesicles of ciclopirox olamine. Drug Dev Ind Pharm, 36:946–953.
   PubMed Web of Science ®Google Scholar
• Marchiori ML, Lubini G, Dalla Nora G, Friedrich RB, Fontana MC, Ourique AF et al. (2010). Hydrogel containing dexamethasone-loaded nanocapsules for cutaneous administration: preparation, characterization, and in vitro drug release study. Drug Dev Ind Pharm, 36:962–971.
   PubMed Web of Science ®Google Scholar
• Yamamoto H. (2007). Application handbook of solubility parameters. Jouhoukikou, Tokyo.
   Google Scholar
• Liron Z, Cohen S. (1984). Percutaneous absorption of alkanoic acids II: Application of regular solution theory. J Pharm Sci, 73:538–542.
   PubMed Web of Science ®Google Scholar
• Hada N, Hasegawa T, Takahashi H, Ishibashi T, Sugibayashi K. (2005). Cultured skin loaded with tetracycline HCl and chloramphenicol as dermal delivery system: mathematical evaluation of the cultured skin containing antibiotics. J Control Release, 108:341–350.
   PubMed Web of Science ®Google Scholar
• Yamaguchi K, Mitsui T, Yamamoto T, Shiokawa R, Nomiyama Y, Ohishi N et al. (2006). Analysis of in vitro skin permeation of 22-oxacalcitriol having a complicated metabolic pathway. Pharm Res, 23:680–688.
   PubMed Web of Science ®Google Scholar
• Higuchi T. (1960). Physical chemical analysis of percutaneous absorption process from creams and ointment. J Soc Cosm Chem, 11:85–97.
   Web of Science ®Google Scholar
• Smith EW, Christian STT, Tassopoulos A, Maibach HI. (2002). Skin applied base ∼comprehensive approach∼. In: Robert L, Bronaugh HI. (eds.), Topical absorption of dermatological products. Fragrance Journal, Tokyo.
   Google Scholar
• Hadgraft J. (2001). Modulation of the barrier function of the skin. Skin Pharmacol Appl Skin Physiol, 14 Suppl 1:72–81.
   PubMedGoogle Scholar
• Dias M, Hadgraft J, Lane ME. (2007). Influence of membrane-solvent-solute interactions on solute permeation in model membranes. Int J Pharm, 336:108–114.
   PubMed Web of Science ®Google Scholar